Back to today’s briefing

Story perspectives

Allurion Technologies Seeks $7.4 Million for Growth

1/25/2025

47 6

Summary

Story summary

Allurion Technologies aims to raise $7.4 million by offering 1.24 million shares at $6.00 each.
The company will also issue warrants for the same number of shares, pending shareholder approval.
Proceeds will fund operational costs and a clinical study on its gastric balloon combined with GLP-1 therapy.
The offering is projected to close around January 27, 2025, with Roth Capital Partners as the placement agent.

History

Historical Context

Allurion Technologies' $7.4 million share offering reflects a historical trend in medtech funding. Since the 2010s, venture capital in health tech surged by 200%, driven by innovations like gastric balloons. This mirrors earlier medical breakthroughs, highlighting ongoing investment in transformative healthcare solutions.

1 of 2

Story summary

Allurion Technologies aims to raise $7.4 million by offering 1.24 million shares at $6.00 each.
The company will also issue warrants for the same number of shares, pending shareholder approval.
Proceeds will fund operational costs and a clinical study on its gastric balloon combined with GLP-1 therapy.
The offering is projected to close around January 27, 2025, with Roth Capital Partners as the placement agent.

1 / 2